2020 - Year of COVID-19.
作者信息
Lillicrap David, Morrissey James H
机构信息
Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
Departments of Biological Chemistry and Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
出版信息
J Thromb Haemost. 2020 Sep;18(9):2081. doi: 10.1111/jth.15041.
Abstract
摘要
相似文献
1
2020 - Year of COVID-19.2020年——新冠疫情之年。
J Thromb Haemost. 2020 Sep;18(9):2081. doi: 10.1111/jth.15041.
2
ISTH DIC subcommittee communication on anticoagulation in COVID-19.ISTH DIC 小组委员会关于 COVID-19 抗凝治疗的沟通。
J Thromb Haemost. 2020 Sep;18(9):2138-2144. doi: 10.1111/jth.15004.
3
COVID-19 update: Covid-19-associated coagulopathy.新型冠状病毒肺炎最新情况：新型冠状病毒肺炎相关凝血病
J Thromb Thrombolysis. 2020 Jul;50(1):54-67. doi: 10.1007/s11239-020-02134-3.
4
The association between treatment with heparin and survival in patients with Covid-19.肝素治疗与 COVID-19 患者生存之间的关联。
J Thromb Thrombolysis. 2020 Aug;50(2):298-301. doi: 10.1007/s11239-020-02162-z.
5
The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.抗凝治疗对新冠病毒感染患者死亡率的影响。
Am J Cardiol. 2020 Nov 1;134:155-157. doi: 10.1016/j.amjcard.2020.08.005. Epub 2020 Aug 15.
6
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.COVID-19 急性呼吸窘迫综合征患者的促凝模式。
J Thromb Haemost. 2020 Jul;18(7):1747-1751. doi: 10.1111/jth.14854. Epub 2020 May 6.
7
COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.新型冠状病毒肺炎凝血功能障碍与炎症：已知与未知
Anesth Analg. 2020 Nov;131(5):1323. doi: 10.1213/ANE.0000000000005215.
8
A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic.一场完美风暴：COVID-19大流行期间维生素K拮抗剂超治疗性抗凝的根本原因分析
Thromb Res. 2020 Aug;192:73-74. doi: 10.1016/j.thromres.2020.05.024. Epub 2020 May 16.
9
Venous Thromboembolism and Heparin Use in COVID-19 Patients: Juggling between Pragmatic Choices, Suggestions of Medical Societies and the Lack of Guidelines.2019冠状病毒病患者的静脉血栓栓塞与肝素使用：在实际选择、医学协会建议及缺乏指南之间权衡
J Thromb Thrombolysis. 2020 Jul;50(1):68-71. doi: 10.1007/s11239-020-02125-4.
10
Current Perspectives of Anticoagulation in Patients With COVID-19.新型冠状病毒肺炎患者抗凝治疗的现状。
J Cardiovasc Pharmacol. 2020 Aug;76(2):146-150. doi: 10.1097/FJC.0000000000000861.
引用本文的文献
1
Tissue factor in COVID-19-associated coagulopathy.COVID-19 相关凝血病中的组织因子。
Thromb Res. 2022 Dec;220:35-47. doi: 10.1016/j.thromres.2022.09.025. Epub 2022 Oct 1.
Zotero 插件